IL6 and diabetes mellitus: Concurrently, pro-inflammatory cytokines such as interleukin-6 (IL-6) and interleukin-12 (IL-12) are frequently elevated in diabetes, contributing to insulin resistance and tissue damage (Kadhim et al., 2018).